Drugs

Headline: Merck’s investigational treatment, zilovertamab vedotin, in conjunction with the standard R-CHP therapy, delivers a complete response rate (CRR) of 100% at a 1.75 mg/kg dose in a Phase 2 trial targeting previously untreated diffuse large B-cell lymphoma (DLBCL). Content: […]

Zentiva AG, a fully-owned subsidiary of Zentiva Pharma GmbH based in Frankfurt am Main, Germany, and part of the Zentiva group, has completed its voluntary public tender for the acquisition of shares in APONTIS PHARMA AG (APONTIS PHARMA). Following the

Novartis has unveiled promising, long-term results from the pivotal phase III ASC4FIRST trial with Scemblix (asciminib), illustrating superior major molecular response (MMR) rates at the 96-week mark. The research compared Scemblix’s MMR rate against investigator-chosen standard-of-care (SoC) tyrosine kinase inhibitors

The experimental drug datopotamab deruxtecan, also known as Dato-DXd, has achieved Breakthrough Therapy Designation (BTD) in the United States. It targets adult patients who suffer from locally advanced or metastatic non-small cell lung cancer (NSCLC) that exhibits epidermal growth factor

Immunovia, a leading firm in pancreatic cancer diagnostics, has announced the triumphant completion of its CLARITI study, short for Clinical Validation of Next-Generation Test for Early-Stage Pancreatic Cancer, aimed at identifying early-stage pancreatic ductal adenocarcinoma (PDAC). The study, which analyzed

SS Innovations, the trailblazer behind India’s groundbreaking SSI Mantra Surgical Robotic System, has reached a significant milestone in the field of medical science by becoming the inaugural company in India to obtain approval from the Central Drugs Standard Control Organization

Inventurus Knowledge Solutions Limited (referred to as the “Company”) is set to launch its initial public offering (“IPO”) of equity shares (termed as “Offer”) on Thursday, December 12th, 2024. The date allocated for Anchor Investor Bidding is Wednesday, December 11th,

Himachal Pradesh, one of the four states initially chosen to develop world-class infrastructure for medical devices under the Central government’s initiative, has decided to retract its plan for a Medical Devices Park due to feasibility issues. Selected alongside Tamil Nadu,

The Karnataka administration has established a panel to delve into the discrepancies in the procurement activities of the Karnataka State Medical Supplies Corporation Limited (KSMSCL). This is specifically in response to the low-quality deliveries of Ringer’s lactate IV fluid that

In an pivotal effort to optimize the certification process for pharmaceutical exporters, the Directorate General of Foreign Trade (DGFT) has introduced the upgraded eCoO 2.0 platform. This enhanced system is designed to simplify the process for issuing Preferential Certificates of